Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 376-400 of 2,022
RecruitingNCT03649581

Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders

This study is looking at compare two subforms of psychotic disorders that have been clinically distinguished in the 1970s for people with Schizophrenia. Taking part may give some people access to compare the two groups of schizophrenic patients, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
RecruitingNCT05929352

Song-making In a Group (SING)

This study is looking at whether a digital support tool can help people with Schizophrenia. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Active Not RecruitingNCT05337904

Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia

This study is looking at whether a digital support tool can help people with Treatment-resistant Schizophrenia or Deep Brain Stimulation. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Spain
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Condition
Schizophrenia
RecruitingNCT05440214

Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis

This study is looking at whether Dialectical Behavior Therapy Skills Training can help people with Psychosis or Suicide. Participants take part in Dialectical Behavior Therapy Skills Training and complete follow-up assessments.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT05550155

Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations

This study is looking at whether Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment can help people with Schizophrenia or Psychosis. Participants take part in Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Schizophrenia
Not Yet RecruitingNCT07086040

Effects of RAS in SZ

This study is looking at whether questionnaires and follow-up can help people with Schizophrenia and schizoaffective disorder. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Taiwan
Sponsor
Shu-Mei Wang
Condition
Schizophrenia
RecruitingNCT05617898

Determining the Role of Social Reward Learning in Social Anhedonia

This study is looking at whether Motivational Interviewing can help people with Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Alabama at Birmingham
Condition
Schizophrenia
Active Not RecruitingNCT07080827

TTM-Based Social Media Psychoeducation for Psychosis

This study is looking at whether psychoeducation can help people with Treatment Compliance, Social Media, or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Istanbul University - Cerrahpasa
Condition
Schizophrenia
RecruitingNCT07056894

Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis

This study is looking at whether treatment with ABCR helps patients with EPP reduce their alcohol and/or cannabis use for people with Psychosis, Alcohol Use Disorder, or Cannabis Use Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 16 Years to 30 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
RecruitingNCT06058702

Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans

This study is comparing Delta-9-THC Very Low Dose with placebo for people with Schizophrenia or Cannabis Use Disorder. Participants receive Delta-9-THC Very Low Dose or placebo and complete study visits and assessments.

SchizophreniaOtherFrom 21 Years to 60 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Active Not RecruitingNCT06304233

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

This observational study is following people with Heart Diseases, Heart, Functional Disturbance, or Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Norway
Sponsor
Norwegian University of Science and Technology
Condition
Schizophrenia
Active Not RecruitingNCT02407808

Cannabinoids, Learning, and Memory

This study is looking at care and outcomes for people with Cannabis or psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research